Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.

Pharmacological research - 1 Apr 2017

Lloret-Linares Célia, Rollason Victoria, Lorenzini Kuntheavy Ing, Samer Caroline, Daali Youssef, Gex-Fabry Marianne, Aubry Jean-Michel, Desmeules Jules, Besson Marie

Abstract excerpt

OBJECTIVES: This retrospective study aimed to assess to what extent an adverse drug reaction (ADR), an abnormal therapeutic drug monitoring (TDM) or a non-response, was attributable to an abnormal cytochrome P450 activity in a psychiatric setting. METHOD: We collected the results of investigations performed in these situations related to psychotropic drugs between January 2005 and November 2014. Activities of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Drug Monitoring

Share to Drug-Related Side Effects and Adverse Reactions

Share to Genotype

Share to Phenotype

Source

Identifiers

PMID: 27378571
DOI: 10.1016/j.phrs.2016.07.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study.PMID 27378571Read ↗

Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry.Semantic proximity Read ↗

[The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].Semantic proximity Read ↗

[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].Semantic proximity Read ↗

Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapySemantic proximity Read ↗

Interpreting and applying CYP450 genomic test results to psychotropic medications.Semantic proximity Read ↗

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.Semantic proximity Read ↗

Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation.Semantic proximity Read ↗

The Role of Pharmacogenetic Testing in Optimizing Antipsychotic TherapySemantic proximity Read ↗

Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19Semantic proximity Read ↗

[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].Semantic proximity Read ↗

Pharmacogenomics Can Enhance Prescribing of Psychiatric Medications.Semantic proximity Read ↗

The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.